{
    "2021-12-01": [
        [
            {
                "time": "",
                "orginal_text": "变异毒株Omicron掀翻全球市场，疫苗股还值得投吗？",
                "features": {
                    "keywords": [
                        "变异毒株",
                        "Omicron",
                        "全球市场",
                        "疫苗股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业：OMICRON毒株引发全球关注 重视疫苗板块机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "OMICRON",
                        "全球关注",
                        "疫苗板块",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}